Early clinical experience of cell-free DNA-based aneuploidy screening: A survey of obstetric sonologists in Australia and New Zealand

Abstract

Background Cell-free DNA-based non-invasive prenatal testing for aneuploidy (NIPT) is now established as the most accurate screening test for trisomy 21. This test became clinically available on a patient-funded basis in Australia and New Zealand in 2013. Aim To investigate the clinical implementation of NIPT use by members of the Australian Association of Obstetrical and Gynaecological Ultrasonologists (AAOGU) during its first year of local availability. Method Email invitations with an embedded link to an anonymous online survey were sent to all 140 members of the AAOGU in December 2013. Results We received 54 responses to the survey (39% response rate). Two thirds of respondents were subs..